Navigation Links
Cowen Healthcare Royalty Partners Raises $1 Billion
Date:1/5/2012

nced investment, financial, legal and operations professionals under the leadership of co-founders Gregory B. Brown, M.D., Todd C. Davis and Clarke B. Futch.

In addition to existing Cowen Royalty limited partners, CHRP II LP's consist of a world-class list of public and corporate pension funds, financial institutions, insurance companies, funds-of-funds and university endowments.

Credit Suisse Securities (USA) LLC acted as exclusive financial advisor/placement agent and Goodwin Procter LLP as legal counsel.

About Cowen Healthcare Royalty Partners

Founded in 2007, Cowen Healthcare Royalty Partners is a global healthcare investment firm with over $1.5 billion of capital under management. The Firm specializes in structured financing solutions for the life sciences industry. For more information, visit www.cowenroyalty.com.

Media Contact:         

Kellie Walsh
914-315-6072
kwalsh@kwmcommunications.com

 


'/>"/>
SOURCE Cowen Healthcare Royalty Partners
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. NeoStem to Present at Cowen Group 31st Annual Health Care Conference on March 7 and 8
2. BioSpecifics Technologies Corp. to Present at Cowen and Company 31st Annual Health Care Conference
3. Amgen to Present at the Cowen and Company 31st Annual Healthcare Conference
4. Neurocrine Biosciences to Present at the Cowen & Co. 31st Annual Health Care Conference
5. Cempra Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
6. Life Technologies to Present at the Cowen and Company 31st Annual Health Care Conference
7. Sangamo BioSciences Announces Presentation at Cowen and Company Health Care Conference
8. Savient to Present at the Cowen and Company 30th Annual Health Care Conference
9. Cowen Healthcare Royalty Partners Establishes Strategic Advisory Board
10. RainDance Technologies Reviews Opportunities for Growth at Cowen Health Care Conference
11. Amgen to Present at the Cowen and Company Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 27, 2015  Pfenex Inc. (NYSE MKT: PFNX), a ... therapeutics, today announced that it will be presenting at ... March 2 nd at 3pm PST. Patrick Lucy, chief ... discussing the current state of the biosimilar industry landscape ... For more information on CALBIO 2015 and ...
(Date:2/27/2015)...   PureTech , a science and technology R&D ... and technologies in the healthcare sector, announced today the ... Member of the Board of Directors of Sanofi, to ... been a pleasure to know Chris for many years ... working together more closely now," said Dr. Robert ...
(Date:2/26/2015)... Feb. 26, 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" ... sciences company that develops and commercializes proprietary technologies and ... and operational results for the fiscal first quarter ended ... are in Canadian dollars (CAD), unless otherwise stated. ... win new business from our existing customers and add ...
(Date:2/26/2015)... FT. LAUDERDALE, Fla. , Feb. 26, 2015 /PRNewswire/ ... discussed growth priorities driven by key research advancements ... Health segments at today,s Bank of America Merrill Lynch ... worldwide met the challenge of building grain supplies the ... expected to continue at the pace of the last ...
Breaking Biology Technology:Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 2DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 3DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 4DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 5
... , PLYMOUTH MEETING, Pa., Nov. 5 ... or the "Company") today announced,that the Company plans to release ... the market closes. , The Company ... November 9, 2009,to discuss third quarter 2009 results. Listeners ...
... ... be stopped. Scott Miller and Company has completed the feature film ... The Human Anthrax Vaccine Story" to inform the public about the clear ... anthrax vaccines with no accountability to its victims. It is available ...
... Nektar Therapeutics (Nasdaq: NKTR ) today reported its financial ... Net loss for the quarter ended September 30, 2009 improved to ... loss of $37.0 million or $0.40 per share in the third ... improvements to its operating efficiencies as compared to a year ago. ...
Cached Biology Technology:BMP Sunstone to Report Third Quarter 2009 Financial Results 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 3Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 5Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 6Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 7Nektar Therapeutics Reports Third Quarter 2009 Financial Results 2Nektar Therapeutics Reports Third Quarter 2009 Financial Results 3Nektar Therapeutics Reports Third Quarter 2009 Financial Results 4Nektar Therapeutics Reports Third Quarter 2009 Financial Results 5Nektar Therapeutics Reports Third Quarter 2009 Financial Results 6Nektar Therapeutics Reports Third Quarter 2009 Financial Results 7Nektar Therapeutics Reports Third Quarter 2009 Financial Results 8Nektar Therapeutics Reports Third Quarter 2009 Financial Results 9Nektar Therapeutics Reports Third Quarter 2009 Financial Results 10
(Date:2/5/2015)... 26, 2015   Epic Sciences , a precision diagnostics ... that Murali Prahalad , Ph.D., president and CEO, is ... (PMWC) 2015: Silicon Valley, which is taking place at ... on January 26-28, 2015. Dr. ... as Biomarkers." Last year, Epic Sciences was a finalist in ...
(Date:2/5/2015)... , Jan. 28, 2015 Research and ... the addition of the "Global Biometrics Market ... Regions and Countries " report to their offering. ... Asia-Pacific is anticipated to ... 2015, owing to increasing government spending towards IT ...
(Date:1/22/2015)... the leading source of biometrics industry news, interviews and thought ... "When we launched FindBiometrics 12 years ago the industry ... and CEO of FindBiometrics. "Now it,s maturing very quickly. More ... on a very broad scale.  We are known for providing ...
Breaking Biology News(10 mins):Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2
... be ,smoked out, of human cells. The so-called ,shock and ... open access journal Retrovirology , might represent a new ... for HIV/AIDS. Dr. Enrico Garaci, president of the ... Dr. Andrea Savarino, a retrovirologist working at the institution, worked ...
... at the University of Delaware have discovered a new reason why ... the most invasive plants in the United States. The UD ... knock-out punch to snuff out its victims, and the poison becomes ... The study, which is published in the June issue of ...
... in the March issue of Human Nature , women ... their subjective ratings of photos of men when considering such ... not have sexual partners spent more time evaluating photos of ... difference was found between men who had sexual partners and ...
Cached Biology News:'Shock and kill' research gives new hope for HIV-1 eradication 2Changing climate likely to make 'super weed' even more powerful 2Single women gaze longer 2
... Peptide-Protein Conjugation, ... Bridges, Complex Peptides/Peptidomimetics, Special ... Phosphorylated/Biotinylated Structures, Peptide labeling AMC, ... -99%, fitting your needs, Chromogenic/Flurogenic ...
... EIA Kit is an in vitro ... determination of human Gla-OC in serum, ... and other biological fluids. This ... It is not for use in ...
Human Aminopeptidase P2/XPNPEP2 Affinity Purified PAb ENTREZ GeneID: 7512...
... host strains are K-12 derivatives that have ... and glutathione reductase (gor) genes, which greatly ... Studies have shown that expression in Origami(DE3) ... another host even though overall expression levels ...
Biology Products: